Brought to you by:
Retrospective study is ‘first to systematically explore predictors of venous stent occlusion’
New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular venous stenting for chronic outflow obstructions is an “efficacious and safe” treatment in selected patients. These findings were…
Venovo venous stent returns to US market after 2021 recall
BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year. In 2019, the company reported that the Food and Drug Administration (FDA) had granted premarket approval for the Venovo venous stent. In…
CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant in the room’
To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts of the world. That was the conclusion delivered by Manj Gohel, MD, of Cambridge University Hospitals,…
The top 10 most popular Vascular Specialist stories in March
Among the posts catching Vascular Specialist readers’ eyes last month were the digital flipbook version of our March print edition, a new study looking at the Society for Vascular Surgery (SVS) open abdominal aortic aneurysm (AAA) recommendations, and an interview…
Database analysis findings ‘matched precisely’ with reported reasons for venous stent recalls
A recent analysis recalled Venovo and Vici venous stents—initiated last year—characterized “significant differences” between reported device and patient issues, and subsequent interventions for the two systems, with findings ultimately matching the reasons given for the recall at the time. A…
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at AVF 2022
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting, held this year Feb. 23–26 in Orlando, Florida. Catching the audience’s attention, researchers highlighted a head-to-head study of dedicated versus non-dedicated stents, as…
Venous stents remain durable following pregnancy, researchers find
Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous insufficiency (PVI), according to new research published in the Journal of Vascular Surgery: Venous and Lymphatic…
Risk of venous stent migration ‘rare’ but probably ‘underreported,’ systematic review finds
Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported,” with the majority of reported cases being shorter and smaller diameter stents. This is the main concluding finding of a systematic review published…
Office-based laboratory setting proves ‘safe’ for iliac vein stenting
A retrospective study of 1,223 iliac vein cases performed in three office-based laboratories (OBLs) demonstrated a major complication rate of 0.41%, suggesting these procedures are safe and well-tolerated in this setting, the authors say. According to corresponding researcher Levan Sulakvelidze,…
VIVID study on Duo venous stent system now fully enrolled, Vesper Medical announces
Vesper Medical recently announced the completion of enrollment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent system). VIVID enrolled its 160th patient earlier this month, marking completion of enrollment in the trial.…